English | Español
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
Patient Daily | Jul 30, 2026

Microbial metabolites may improve functional cure rates for hepatitis B
Patient Daily | Jul 30, 2026

NYU Langone and Dana-Farber launch new oncology platform to support cancer care
Patient Daily | Jul 30, 2026

Dual immunotherapy with chemotherapy shows activity in HER2-negative breast cancer trial
Patient Daily | Jul 30, 2026

Texas A&M researchers develop AI tools to streamline tuberculosis drug discovery process
Patient Daily | Jul 30, 2026

FDA advisory committee votes in favor of Replimune’s melanoma therapy despite data concerns
Patient Daily | Jul 30, 2026

Biopharma employees describe impersonal and abrupt layoff notifications
Patient Daily | Jul 30, 2026

Zeus earns Intertek PFAS-free certification for PFX Flex catheter liners

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+ Pharmaceuticals
Patient Daily | Jul 30, 2026

Jefferies analysts say Daiichi Sankyo’s pipeline lags as cash flow nears peak
+ Pharmaceuticals
Patient Daily | Jul 29, 2026

AI-enabled tool linked to fewer deaths among high-risk hospitalized patients, study finds